INTRODUCTION
Arthritic conditions are characterized by the breakdown of extracellular matrix components and the subsequent loss of articular cartilage and bone. This process is thought to be mediated by excessive proteolytic activity. 1 Cartilage oligomeric matrix protein (COMP), a prominent noncollagenous component of cartilage, accounts for approximately 1% of the wet weight of the tissue. 2 COMP is a 524 kDa disulfide-bonded, multidomain glycoprotein composed of five 110 kDa subunits ( Figure 1 ). Mutations in the type III or C-terminal globular domain of the human COMP gene have been linked to the development of pseudoachondroplasia and multiple epiphyseal dysplasia, which are autosomal-dominant forms of short-limb dwarfism. [3] [4] [5] [6] Fragments of COMP have been detected in the diseased cartilage, synovial fluid, and serum of patients with knee injuries, post-traumatic, primary osteoarthritis (OA) and rheumatoid arthritis (RA). 7, 8 As the inhibition of cartilage degradative enzymes should slow or block disease progression, the isolation of these enzymes and their inhibitors is of great interest from both a pathophysiological and a therapeutic standpoint. Purified COMP has been reported to be digested by several matrix metalloproteinases (MMPs) in vitro, including MMP-1 (also known as interstitial collagenase-1), MMP-13 (also known as collagenase-3), MMP-3 (also known as stromelysin-1), MMP-9 (also known as gelatinase-B), 9 MMP-19 and MMP-20 (also known as enamelysin). 10 In addition, a member of the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) family, ADAMTS-4, was reported to cleave purified COMP in vitro. 11 All these assays, however, were performed using an in vitro digestion system with higher concentrations of enzymes and substrates than are found in physiological and pathological conditions. COMP degradation in vivo is probably mediated, at least in part, by these metalloproteinases, although no relationship between COMP degradation and ADAMTS levels has been found to date.
A functional genomic study that was performed to identify the physiological enzymes responsible for COMP degradation led to the isolation of ADAMTS-7 and ADAMTS-12 as COMP-binding partners. 12, 13 Subsequent studies showed that both ADAMTS-7 and ADAMTS-12 were able to digest COMP in vitro, and were significantly upregulated in arthritic cartilage and synovium compared with normal control samples. 12, 13 ADAMTS-7 and ADAMTS-12 have a similar domain organization, and form a subgroup within the ADAMTS family (Figure 2 ). ADAMTS are secreted zinc metalloproteinases with a precisely ordered, modular organization that includes at least one thrombospondin type 1 repeat. 14 This family of enzymes has been shown to be proteolytically active; Table 1 summarizes the known substrates and inhibitors of these proteases. ADAMTS have been implicated in the pathogenesis of several diseases. [15] [16] [17] [18] [19] [20] For instance, mutations in ADAMTS-13 are associated with the development of thrombotic thrombocytopenic purpura, a disease characterized by decreased numbers of circulating platelets. 21 Mutations in the ADAMTS-2 gene have been implicated in Ehlers-Danlos syndrome type 7C, a genetic condition characterized by defects in collagen synthesis. 22 These mutations have also been observed in bovine dermatopraxis. 22 Similar to ADAMTS-4, 11 ADAMTS-5 (also known as ADAMTS-11) has been associated with the breakdown of cartilage via aggrecan degradation. [23] [24] [25] [26] [27] Several single nucleotide polymorphisms in the ADAMTS-7 gene have been identified that suggest a strong association with the disease haplotype of keratoconus with cataract. 28 ADAMTS-7 is expressed in bone, cartilage, synovium, tendon and ligament, all of which contain COMP. 2,29 ADAMTS-7 is also detectable, although at lower levels, in meniscus, skeletal muscle and fat. 12 Interestingly, ADAMTS-7 was identified as one of three high-molecular-weight gelatinase species in the urine of patients with a variety of cancers, including prostate and bladder carcinoma. 30 The observation that ADAMTS-7 has gelatinolytic activity in patients with prostate and bladder tumors suggests a functional role for this protease in tumor growth and invasion. 30 ADAMTS-12 is one of three genes associated with bronchial hyper-responsiveness. 31 One study showed that the expression of ADAMTS-12 in Madin-Darby canine kidney cells prevented the tumorigenic effects of hepatocyte growth factor by blocking activation of the Ras-mitogenactivated protein kinase signaling pathway, and that this regulation involved the thrombospondin domains of the metalloproteinase. 32 Unlike ADAMTS-7, which does not cleave aggrecan or versican, 33 ADAMTS-12 is able to digest aggrecan in vitro. 32 Northern blot analysis of RNA from human adult and fetal tissues demonstrated that ADAMTS-12 transcripts are only detected at considerable levels in fetal lung. 34 However, a real-time polymerase chain reaction (PCR) assay revealed that ADAMTS-12 is detectable in cartilage, synovium, tendon, skeletal muscle and fat. 13 In addition, expression profiling analysis of the ADAMTS family revealed that ADAMTS-12 was significantly upregulated in cartilage from patients with OA compared with normal cartilage. 35 This Review focuses on the roles of ADAMTS-7 and ADAMTS-12 in the pathogenesis of arthritic disease, including the association between these two metalloproteinases and COMP and their possible involvement in COMP degradation, as well as the inhibition of their activities as a ncprheum_2008_120f1.eps potential therapeutic strategy for the treatment of arthritis. 12 The interaction between COMP and ADAMTS-7 was confirmed using an in vitro glutathione S-transferase (GST) pulldown assay. 12 A purified recombinant ADAMTS-7 C-terminal GST fusion protein (GST7-CT) was immobilized and incubated with purified humanized COMP. GST7-CT, but not purified GST, was shown to bind efficiently to humanized COMP. The in vivo interaction between COMP and ADAMTS-7 was verified using a co-immunoprecipitation assay. A specific ADAMTS-7 protein was recognized by anti-COMP, but not control, IgG antibodies, demonstrating that ADAMTS-7 binds specifically to COMP in vivo. 12 Similar protein-protein interactions were employed to demonstrate the binding of COMP to ADAMTS-12. 13 In order to identify the COMP-binding motif in ADAMTS-7 and ADAMTS-12, constructs were generated that expressed their various deletion mutations. 12,13 Results from filter-based β-galactosidase assays of these mutants showed that four C-terminal thrombospondin repeats of ADAMTS-7 or ADAMTS-12 were required for the interaction between these enzymes and COMP.
Immunostaining for COMP and ADAMTS-7 in human chondrocytes demonstrated that COMP co-localized with ADAMTS-7 predominantly in the cytoplasm and surface of chondrocytes. Co-localization of COMP and ADAMTS-12 in human chondrocytes was observed using the same approach. These findings are in agreement with the interactions detected in the yeast twohybrid and co-immunoprecipitation assays, and indicate that the membrane binding of ADAMTS-7 and ADAMTS-12 in chondrocytes might be mediated, at least in part, by COMP.
Immunohistochemistry assays were performed on 17.5-day-old embryonic murine limbs to determine whether COMP, ADAMTS-7 and ADMATS-12 show overlapping expression patterns in vivo. 12,13 Consistent with previous findings, COMP was expressed both in chondrocytes and osteoblasts. Furthermore, ADAMTS-7 and ADAMTS-12 were highly expressed in the proliferative and pre-hypertrophic zones of growth 
COMP-DeGRADING ACTIvITIeS OF ADAMTS-7 AND ADAMTS-12
It has been reported that the catalytic domain of ADAMTS-20 produced in transgenic bacteria can digest its substrates in vitro. 39 Using a similar method, we purified the catalytic domain of ADAMTS-7 as a GST fusion protein in bacteria.
The recombinant catalytic domain of ADAMTS-7 was shown to digest COMP in a time-dependent manner. 12 The COMP-degrading activity of ADAMTS-7 was also demonstrated using the recombinant intact enzyme. Intriguingly, two 51-95 kDa fragments were seen in addition to the predominant 100 kDa fragment produced with the catalytic domain alone, suggesting that recombinant ADAMTS-7 might cleave COMP at more than one site. 12 Furthermore, co-transfection and in vitro digestion assays with conditioned medium or purified ADAMTS-12 indicated efficient COMP degradation by this enzyme. 13 THe IMPORTANCe OF ADAMTS-7 AND ADAMTS-12 CleAvAGe OF COMP
To elucidate the importance of ADAMTS-7-mediated or ADAMTS-12-mediated COMP degradation in vivo, it was necessary to determine whether cartilage from OA patients contained COMP fragments of a similar size to those seen in ADAMTS-7-mediated or ADAMTS-12-mediated COMP digestion in vitro. To this end, cartilage explants from six patients with OA were compared with COMP fragments produced by in vitro digestion with recombinant ADAMTS-7 or ADAMTS-12 using western blotting with anti-COMP antibodies. All OA cartilage samples contained abundant fragments of a similar size to those produced by ADAMTS-12 and ADAMTS-7 degradation of COMP (110 kDa). 40 We then investigated whether tumor necrosis factor (TNF) and interleukin (IL)-1β regulate the expression of ADAMTS-7 and ADAMTS-12. These inflammatory cytokines have previously been shown to induce the expression of a number of metalloproteinases involved in the development and progression of arthritis. [41] [42] [43] Human cartilage explants were cultured in the presence of TNF or IL-1β for 1 day, and real-time PCR was performed. Both TNF and IL-1β strongly induced mRNA expression of ADAMTS-7 and ADAMTS-12 compared with untreated tissues. 40 However, in human fetal fibroblasts, only TGF-β has been shown to significantly induce the expression of ADAMTS-12, 34 suggesting that cytokine-mediated induction of ADAMTS-12 expression might be cell-type specific.
To determine whether ADAMTS-7 and ADAMTS-12 are directly involved in COMP degradation induced by TNF and IL-1β, COMP degradation was compared in the absence and presence of antibodies that block ADAMTS-12 and ADAMTS-7 activity. 12 Both cytokines resulted in the expression of 110 kDa COMP fragments, which was dramatically reduced in the presence of anti-ADAMTS-12 or anti-ADAMTS-7 antibodies. In addition, COMP degradation was blocked completely by a combination of these two antibodies, and intact COMP (524 kDa) was observed, indicating that ADAMTS-12 and ADAMTS-7 have important roles in TNFinduced and IL-1β-induced COMP degradation. The importance of these two enzymes in COMP degradation in vivo was further verified via small interfering RNA-mediated silencing of ADAMTS-7 and ADAMTS-12 in human chondrocytes. 40 Of course, a direct correlation between COMP cleavage sites in vitro and in vivo remains to be determined. Specifically, the importance of ADAMTS-7 and ADAMTS-12 in COMP degradation and arthritis could be more substantially established by the generation of mutant mice lacking ADAMTS-7 or ADAMTS-12 in order to observe their phenotype when challenged in a model of arthritis. Indeed, this approach has previously been used to reveal a primary role for ADAMTS-5 in aggrecan degradation, both in surgically induced OA and in antigen-induced inflammatory arthritis. 18,44
INCReASeD eXPReSSION OF ADAMTS-7 AND ADAMTS-12 IN RA
A quantitative real-time PCR assay was performed using sequence-specific probes and primers for ADAMTS-7 and ADAMTS-12 to determine whether the expression of these enzymes differs in OA and RA cartilage. ADAMTS-7 mRNA was found to be significantly upregulated in RA cartilage (P <0.001), and only slightly upregulated in OA cartilage, whereas ADAMTS-12 mRNA was significantly upregulated in both OA and RA cartilage (P <0.05 and P <0.001, respectively) compared with normal cartilage. These results confirm the findings of a real-time PCR assay that showed no significant differences in ADAMTS-7 expression between normal and OA cartilage (I Clark, personal communication), as well as significant upregulation of ADAMTS-12 in OA cartilage. 35 In addition, altered expression of ADAMTS-7 and ADAMTS-12 both in OA and RA synovium was observed. 12,13
INHIBITION OF ADAMTS-7 AND ADAMTS-12
α 2 -Macroglobulin (α 2 M) is a member of the α-macroglobulin family of proteins found in the circulation of a broad range of species. 45 Human α 2 M is found at relatively high levels (2-4 mg/ml) in plasma, and is a tetramer of four identical 185 kDa subunits, each of which has an exposed 39-amino-acid 'bait region' that contains cleavage sites for a variety of proteinases. 46,47 Previous reports have shown an association between α 2 M and ADAMTS-7, 33 and it is known that α 2 M inhibits ADAMTS-4 and ADAMTS-5 by competitive inhibition of cleavage activity by the bait region of ADAMTS-4 and ADAMTS-5. 48 In vitro digestion assays demonstrated that α 2 M acts as a substrate for ADAMTS-7 and ADAMTS-12, and efficiently protects COMP degradation by these enzymes. 40 One study reported that granulin-epithelin precursor (GEP; also known as PC-cell derived growth factor, progranulin, proepithelin and acrogranin) is highly expressed in chondrocytes of the musculoskeletal system. 49 Furthermore, COMP directly bound GEP and was shown to enhance GEP-mediated chondrocyte proliferation. GEP was first purified as a growth factor from conditioned tissue culture media in the early 1990s. 50, 51 GEP is a 593-aminoacid secreted glycoprotein with an apparent molecular weight of 80 kDa, 52, 53 and acts as an autocrine growth factor. GEP contains sevenand-a-half repeats of a cysteine-rich motif. Notably, GEP undergoes proteolytic processing with the liberation of small (~6 kDa) repeat units known as granulins (or epithelins), which retain biologic activity. 54 The findings that COMP associates with ADAMTS-7 and ADAMTS-12 12,13 and interacts with GEP 49 led to studies to determine whether GEP binds to ADAMTS-7 and ADAMTS-12. Unpublished data revealed that this was the case (Luan Y et al., personal communication). In addition, ADAMTS-7 and ADAMTS-12 are novel GEP-convertases and are involved in the proteolytic processing of GEP, with the liberation of smaller fragments.
Previous reports suggest that GEP is strongly upregulated in the synovium of both OA and RA. 55 In addition, GEP is a potent inhibitor of TNF-induced protease, 56 and a processed granulin (a product of GEP cleavage) functions as an inhibitor of the protease thrombin. 57 These facts, together with the finding that GEP disturbs the interactions between COMP and ADAMTS-7 and ADAMTS-12, led us to question whether GEP functions as a specific inhibitor of COMP degradation by ADAMTS-7 and ADAMTS-12. Co-expression of GEP in the ADAMTS-7-transfected COMP stable line resulted in dosedependent blockade of COMP degradation by ADAMTS-7 (C-J Liu, unpublished data). Additionally, GEP was shown to prevent ADAMTS-12-associated COMP degradation in an in vitro digestion assay (C-J Liu, unpublished data).
These findings, together with the observations that TNF induces ADAMTS-7 and ADAMTS-12 expression 40 and that GEP blocks TNF-induced proteinase, 56 suggest that GEP regulates ADAMTS-7 at two levels: first, GEP inhibits TNFinduced ADAMTS-7 expression, and second, GEP disrupts the association of ADAMTS-7 enzyme and its COMP substrate via a direct protein-protein interaction (Figure 3) . Thus, in contrast to α 2 M, which has been shown to inhibit the activity of several enzymes, including ADAMTS-4 and ADAMTS-5, 48,58 GEP may represent a specific natural inhibitor of COMP degradation by ADAMTS-7 and ADAMTS-12.
The inhibition of ADAMTS-7 and ADAMTS-12 or their analogous compounds represents a potential novel approach for the treatment of arthritic disorders. Furthermore, it is conceivable that ADAMTS-7 and ADAMTS-12 might be employed as novel biomarkers for arthritic disease activity.
CONClUSIONS
In industrialized societies, arthritis is the leading cause of physical disability, increased healthcare usage and impaired quality of life. The impact of arthritic conditions is expected to grow as the population continues to age in the coming decades. The understanding of the precise etiology, pathogenesis and progression of arthritic diseases remains beyond our reach; however, accumulating evidence points to a significant role for proteases in the pathological processes of arthritis. 1 The destruction of the extracellular matrix of articular cartilage and bone in arthritic joints is thought to be mediated by excessive proteolytic activity. 1 Several recent studies suggest that monitoring of COMP levels (in both joint fluid and serum) can be used to assess the risk, presence and progression of arthritis. [61] [62] [63] [64] Furthermore, altered COMP distribution patterns and degradation rates have been observed in human OA and RA cartilage. 7,8 Using a functional genomic approach combined with biochemistry and cellular and molecular biology techniques, two novel enzymes that belong to the ADAMTS metalloproteinase family, ADAMTS-7 and ADAMTS-12, have been shown to physically associate with and degrade COMP. 12,13 In addition, α 2 M and GEP were identified as substrates of ADAMTS-7 and ADAMTS-12, and can inhibit the degradation of COMP by these enzymes (Figure 3) . 40 These findings not only extend our understanding of the degradative events involved in arthritic disorders, but also promise to increase our ability to monitor the biological and physical properties of cartilage extracellular matrix that could be altered by a wide range of disease processes.
KeY POINTS
■ ADAMTS-7 and ADAMTS-12, two members of the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) family, associate with and degrade cartilage oligomeric matrix protein (COMP) in vitro, and are significantly induced in the cartilage and synovium of patients with rheumatoid arthritis ■ The size of COMP fragments generated by ADAMTS-7 or ADAMTS-12 is similar to that of COMP-degradative fragments seen in arthritic patients ■ Blockade of ADAMTS-7 and ADAMTS-12 activity by specific antibodies or suppression of ADAMTS-7 and ADAMTS-12 expression by the small interfering RNA silencing approach dramatically inhibits tumor necrosis factorinduced and interleukin-1β-induced COMP degradation ■ ADAMTS-7-mediated and ADAMTS-12-mediated COMP degradation is inhibited by α2-macroglobulin ■ Granulin-epithelin precursor, a newly identified chondrogenic growth factor, disturbs the interaction between COMP and ADAMTS-7 and ADAMTS-12, and prevents COMP degradation by these enzymes 
